>

Case Studies

Filtered by Service Areas
Filtered by Therapeutic Areas
arrow&v
arrow&v

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Therapeutic Area

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Therapeutic Area

What can portfolio management do for molecule teams?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management (Molecule Teams)

Therapeutic Area

N/A

What can portfolio management do for early commercialization?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management (Early Commercialization)

Therapeutic Area

N/A

What can portfolio management do for governance?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management (Governance)

Therapeutic Area

N/A

Website assessment for early stage biopharmaceutical company

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Qualitative)

Therapeutic Area

Central Nervous System (Alzheimer's, Lysosomal Storage Disorders)

Market research for novel cell transplant procedure

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Qualitative)

Therapeutic Area

Oncology (ASCT)

Support services optimization for orphan specialty product portfolio

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research

Therapeutic Area

Gene Therapy & Orphan Disease (Orphan)

Demand modeling and scenario planning for a novel, mass-market agent for hypercholesterolemia

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Demand Modelling, Scenario Planning)

Therapeutic Area

Other Therapeutic Areas (Cardiovascular)

Positioning for a novel, ultra-orphan specialty drug: KOL and payer deep dive

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (KOL, Payor, Benchmarking)

Therapeutic Area

Gene Therapy & Orphan Disease (Orphan)

What is the market potential for a novel formulation for treating Diabetic Foot Ulcers?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Market Forecast, TPP Development)

Therapeutic Area

Other Therapeutic Areas (Diabetic Foot Ulcer)

How to forecast R&D costs and allocate resources appropriately for a rare disease company?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management (Activity-Based Costing)

Therapeutic Area

Gene Therapy & Orphan Drugs (Orphan)

Process overhaul at a Top 5 pharma

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management

Therapeutic Area

N/A

What is the go-to-market strategy in the U.S. for an Asia-based medical device startup company?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Go-to-market Strategy, Valuation, Investment Deck Preparation)

Therapeutic Area

Other Therapeutic Areas (Medical Devices)

Analytical model to understand IP-driven commercial risks to an oncology portfolio

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Modeling, Intellectual Property)

Therapeutic Area

Oncology (Immuno-oncology)

Determine the better investment (in-house vs in-license) option for a small molecule drug

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Valuation, Business Development)

Therapeutic Area

Central Nervous System (Parkinson's, ALS)

Develop a strategic outlook for an infectious disease (ID) area and define organizational framework

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (TPP Development, Disease Area Strategy)

Therapeutic Area

Other Therapeutic Areas (Infectious Disease)

Platform technology technical evaluation and deal trends

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Technical Assessment)

Therapeutic Area

Other Therapeutic Areas (CAR-T, CRISPR), Gene Therapy

Strategic competitive intelligence assessments

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Competitive Insights)

Therapeutic Area

Central Nervous System (Alzheimer's, Parkinson's, ALS)

Immuno-oncology competitive intelligence

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Competitive assessment)

Therapeutic Area

Oncology (Solid Tumor, Immuno-oncology)

Technology prioritization for stem cell (iPSC) regenerative medicine technology

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Technical Assessment)

Therapeutic Area

Oncology (Stem Cell)

Landscape assessment, development opportunities, and forecasting for novel prostate cancer molecule

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Market Forecast, Competitive Assessment)

Therapeutic Area

Oncology (Solid Tumor, Prostate)

Market forecast and technology valuation for a novel immuno-oncology cell therapy

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Valuation and Market Forecast)

Therapeutic Area

Oncology (Cell Therapy, Hematology)

Detailed global sales forecast and NPV model in Ulcerative Colitis and Crohn’s Disease

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Valuation)

Therapeutic Area

Auto-immune (UC and Crohn's)

Indication prioritization for platform technology

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Assessment)

Therapeutic Area

Central Nervous System (Alzheimer's)

How to prioritize indications for an early stage company with a disruptive technology?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Central Nervous System

Portfolio planning and management

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

Company Strategy Alignment

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Corporate Strategy)

Therapeutic Area

Infectious Disease

Indication evaluation and prioritization for development stage pharmaceutical client

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

How to prioritize indications for an early stage company with a disruptive technology?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

On-demand, Short-term Ops Support for a Pre-IND Biotech

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Operation Strategy (CMC)

Therapeutic Area

Oncology, Other Therapeutic Areas

Assess the biosimilars market and create a medical affairs strategy to prepare for biosimilar launches

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Operation Strategy (medical affairs)

Therapeutic Area

Oncology (immunoncology)

Launch messaging and positioning for a specialty product

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (launch messaging and positioning)

Therapeutic Area

Gene Therapy & Orphan Disease

Market research for novel oncology drug with NGS vs. IHC diagnostic strategy

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Quantitative and Qualitative Study)

Therapeutic Area

Oncology (diagnostics, NGS, Solid Tumor)

US quantitative market assessment: novel therapy for infectious disease

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Market Research (Quantitive & Qualitative Study, TPP testing, Market Forecast Research)

Therapeutic Area

Other Therapeutic Areas (Infectious Disease, Tuberculosis)

Analytics overhaul at a top 10 pharma

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Portfolio Management

Therapeutic Area

N/A

Pre-clinical Stage, Cutting Edge Biotech in Need of Strategy and Analysis Leverage

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy

Therapeutic Area

Central Nervous System

What is the product positioning strategy for two novel early stage IO candidates for global pharma company?

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy, Portfolio Management (Disease Area Strategy)

Therapeutic Area

Oncology (Solid Tumor), Auto-immune

Quantitative market assessment of preselected diseases and selection of potential new indications

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Services Area

Commercial Strategy (Indication Prioritization), Portfolio Management

Therapeutic Area

Gene Therapy & Orphan Disease

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net